Plantibodies: Applications, advantages and bottlenecks

Current Opinion in Biotechnology

Volumn 13, Issue 2, 2002, Pages 161-166

  Stoger, Eva ^a   Sack, Markus ^b   Fischer, Rainer ^b   Christou, Paul ^b  

^a JOHN INNES CENTRE   (United Kingdom)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; RECOMBINANT ANTIBODY;

ANTIBODY ENGINEERING; ANTIBODY PRODUCTION; BIOREACTOR; DISEASE RESISTANCE; GENE EXPRESSION; GENETIC TRANSFORMATION; GLYCOSYLATION; IMMUNOMODULATION; NONHUMAN; PHENOTYPE; PLANT BIOTECHNOLOGY; PLANT DEVELOPMENT; PRIORITY JOURNAL; PURIFICATION; REVIEW; TRANSGENIC PLANT;

EID: 0036535775     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(02)00303-8     Document Type: Review

References (53)

1. Production of antibodies in transgenic plants
2. Molecular farming of pharmaceutical proteins
3. Transgenic plants as factories for biopharmaceuticals
4. Production of secretory IgA antibodies in plants
5. Producing proteins in transgenic plants and animals
6. Therapeutic antibody expression technology
7. High-level expression of a single-chain Fv fragment (scFv) antibody in transgenic pea seeds
8. Expression and long-term stability of a recombinant single-chain Fv antibody fragment in transgenic Nicotiana tabacum seeds
9. Foreign protein production in plant tissue cultures
10. Strategies for enhancing monoclonal antibody accumulation in plant cell and organ cultures
11. Characterization of monoclonal antibody fragments produced by plant cells
12. Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts
13. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants
14. The expression of a single-chain Fv antibody fragment in different plant hosts and tissues by using potato virus X as a vector
15. Facile assessment of cDNA constructs for expression of functional antibodies in plants using the potato virus X vector
16. Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves
17. A carcinoembryonic antigen-specific diabody produced in tobacco
18. Plants as bioreactors for protein production: Avoiding the problem of transgene silencing
19. Silencing of antibody genes in plants with single-copy transgene inserts as a result of gene dosage effects
20. Analysis of the interaction between single-chain variable fragments and their antigen in a reducing intracellular environment using the two-hybrid system
21. Stability engineering of antibody single-chain Fv fragments
22. Highly efficient targeting and accumulation of a Fab fragment within the secretory pathway and apoplast of Arabidopsis thaliana
23. Assembly, secretion, and vacuolar delivery of a hybrid immunoglobulin in plants
24. Native and artificial reticuloplasmins co-accumulate in distinct domains of the endoplasmic reticulum and in post-endoplasmic reticulum compartments
25. Assembly and plasma membrane targeting of recombinant immunoglobulin chains in plants with a murine immunoglobulin transmembrane sequence
26. Antibody-based resistance to plant pathogens
27. The plantibody approach: Expression of antibody genes in plants to modulate plant metabolism or to obtain pathogen resistance
28. Monoclonal antibodies incorporated into Neotyphodium coenophialum fungal cultures: Inhibition of fungal growth and stability of antibodies
29. Immunomodulation of phytohormones and functional proteins in plant cells
30. Expression of an abscisic acid-binding single-chain antibody influences the subcellular distribution of abscisic acid and leads to developmental changes in transgenic potato plants
31. Immunomodulation of ABA function affects early events in somatic embryo development
32. Medical molecular farming: Production of antibodies, biopharmaceuticals and edible vaccines in plants
33. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans
34. A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes
35. Expression of a functional antizearalenone single-chain Fv antibody in transgenic Arabidopsis plants
36. Expression and characterisation of single-chain antibody fragments produced in transgenic plants against the organic herbicides atrazine and paraquat
37. Practical considerations for pharmaceutical antibody production in different crop systems
38. Effect of climate conditions and plant developmental stage on the stability of antibodies expressed in transgenic tobacco
39. Corn seed production of therapeutic proteins moves forward: One company's experience
40. Species-specific variation in glycosylation of IgG: Evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics
41. N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants
42. A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice
43. Galactose-extended glycans of antibodies produced by transgenic plants
44. Influence of growth conditions and developmental stage on N-glycan heterogeneity of transgenic immunoglobulin G and endogenous proteins in tobacco leaves
45. The regulation of biologic products derived from bioengineered plants
46. Plants as bioreactors for biopharmaceuticals: Regulatory considerations
47. A self-contained system for the field production of plant recombinant interleukin-10
48. Tandem constructs: Preventing the rise of superweeds
49. Therapeutic antibody production technologies: Molecules, applications, expression and purification
50. An anti-HSV antibody produced in transgenic rice plants prevents vaginal HSV-2 infection in mice
51. Production of a diagnostic monoclonal antibody in perennial alafalfa plants
52. Expression and assembly of a full-length monoclonal antibody in plants using a plant virus vector